NEJM· @NEJM · X·· 2026-10-18AI 评分30
AI 导读
靶向白细胞介素-23通路的单克隆抗体,经静脉或皮下给药,在炎症性肠病中有效。ANTHEM-UC试验的研究结果在一段新的Quick Take视频中进行了总结。https://nej.md/4s4CROE
正文
Monoclonal antibodies targeting the interleukin-23 pathway, given intravenously or subcutaneously, are effective in inflammatory bowel disease. Research findings from the ANTHEM-UC trial are summarized in a new Quick Take video. https://nej.md/4s4CROE
来源:NEJM · x.com